Turtle Creek Wealth Advisors’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
EIG
Turtle Creek Wealth Advisors's DGX Position: Q2 2026 in Review
Turtle Creek Wealth Advisors increased its Quest Diagnostics (DGX) stake by 12% in Q2 2026, buying an estimated $34.9K and bringing the position to 1,654 shares worth $351K. The position accounts for 0.02% of the portfolio, ranked #335.
Turtle Creek Wealth Advisors first reported a position in DGX in Q4 2023 and has held it in 6 quarters since. 1,107 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Turtle Creek Wealth Advisors held 1,654 shares of Quest Diagnostics worth $351K as of Q2 2026.
- Turtle Creek Wealth Advisors bought 178 Quest Diagnostics shares in Q2 2026, an estimated $34.9K.
- Quest Diagnostics made up 0.02% of Turtle Creek Wealth Advisors's portfolio in Q2 2026, its #335 holding.
- Turtle Creek Wealth Advisors first reported a position in Quest Diagnostics in Q4 2023 and has held it in 6 quarters since.
- 1,107 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Turtle Creek Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.